Amyloid-β 2 protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease

Nature Chemistry

Volumn 1, Issue 4, 2009, Pages 326-331

  Bernstein, Summer L ^a   Dupuis, Nicholas F ^a   Lazo, Noel D ^b   Wyttenbach, Thomas ^a   Condron, Margaret M ^c   Bitan, Gal ^c   Teplow, David B ^c,d   Shea, Joan Emma ^a   Ruotolo, Brandon T ^e   Robinson, Carol V ^e   Bowers, Michael T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CLARK UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); ISOPROTEIN; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; CHEMISTRY; HUMAN; MASS SPECTROMETRY; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PARKINSON DISEASE; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; DIABETES MELLITUS, TYPE 2; HUMANS; MASS SPECTROMETRY; PARKINSON DISEASE; PEPTIDE FRAGMENTS; PLAQUE, AMYLOID; PROTEIN ISOFORMS;

EID: 67849106670     PISSN: 17554330     EISSN: 17554349     Source Type: Journal    
DOI: 10.1038/nchem.247     Document Type: Article

References (32)

1. Meier, J. J. et al. Inhibition of human IAPP fibril formation does not prevent β-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. Am. J. Physiol. Endocrinol. Metab. 291, E1317-E1324 (2006).
2. Conway, K. A. et al. Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc. Natl Acad. Sci. USA 97, 571-576 (2000).
3. Klein, W. L., Krafft, G. A. & Finch, C. E. Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24, 219-224 (2001).
4. Kirkitadze, M. D., Bitan, G. & Teplow, D. B. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J. Neurosci. Res. 69, 567-577 (2002).
5. Cheng, I. H. et al. Accelerating amyloid-β fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J. Biol. Chem. 282, 23818-23828 (2007).
6. Lesne, S. et al. A specific amyloid-β protein assembly in the brain impairs memory. Nature 440, 352-357 (2006).
7. Lazo, N. D., Maji, S. K., Fradinger, E. A., Bitan, G. & Teplow, D. B. in Amyloid Proteins: The Beta Sheet Conformation and Disease (ed. Sipe, J. D.) 385-491 (Wiley, 2005).
8. Bitan, G., Lomakin, A. & Teplow, D. B. Amyloid β-protein oligomerization. Prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J. Biol. Chem. 276, 35176-35184 (2001).
9. Bitan, G., Vollers, S. S. & Teplow, D. B. Elucidation of primary structure elements controlling early amyloid β-protein oligomerization. J. Biol. Chem. 278, 34882-34889 (2003).
10. Bitan, G. et al. Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc. Natl Acad. Sci. USA 100, 330-335 (2003).
11. Chen, Y.-R. & Glabe, C. G. Distinct early folding and aggregation properties of Alzheimer amyloid-β peptides Aβ40 and Aβ42: stable trimer or tetramer formation by Aβ42. J. Biol. Chem. 281, 24414-24422 (2006).
12. Bitan, G., Fradinger, E. A., Spring, S. M. & Teplow, D. B. Neurotoxic protein oligomers - what you see is not always what you get. Amyloid 12, 88-95 (2005).
13. von Helden, G., Hsu, M.-T., Kemper, P. R. & Bowers, M. T. Structures of carbon cluster ions from 3 to 60 atoms: linears to rings to fullerenes. J. Chem. Phys. 95, 3835-3837 (1991).
14. Wyttenbach, T. & Bowers, M. T. Gas-phase conformations: the ion mobility/ion chromatography method. Top. Curr. Chem. 225, 207-232 (2003).
15. 19 alloform. J. Am. Chem. Soc. 127, 2075-2084 (2005).
16. Hou, L., Kang, I., Marchant, R. E. & Zagorski, M. G. Methionine 35 oxidation reduces fibril assembly of the amyloid Aβ-(1-42) peptide of Alzheimer's disease. J. Biol. Chem. 277, 40173-40176 (2002).
17. Wood, S. J., Wetzel, R., Martin, J. D. & Hurle, M. R. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide β/A4. Biochemistry 34, 724-730 (1995).
18. Klein, W. L., Stine, W. B. Jr & Teplow, D. B. Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiol. Aging 25, 569-580 (2004).
19. 35 and amyloid β-protein oligomerization. J. Am. Chem. Soc. 125, 15359-15365 (2003).
20. n oligonucleotides in a solvent-free environment. J. Am. Chem. Soc. 126, 15132-15140 (2004).
21. Baumketner, A. et al. Amyloid β-protein monomer structure: a computational and experimental study. Protein Sci. 15, 420-428 (2006).
22. Maji, S. K., Amsden, J. J., Rothschild, K. J., Condron, M. M. & Teplow, D. B. Conformational dynamics of amyloid β-protein assembly probed using intrinsic fluorescence. Biochemistry 44, 13365-13376 (2005).
23. Wyttenbach, T., von Helden, G., Batka, J. J., Carlat, D. & Bowers, M. T. Effect of the long-range potential on ion mobility measurements. J. Am. Soc. Mass Spectrom. 8, 275-282 (1997).
24. Oosawa, F. & Kasai, M. Theory of linear and helical aggregations of macromolecules. J. Mol. Biol. 4, 10-21 (1962).
25. Tobacman, L. S. & Korn, E. D. The kinetics of actin nucleation and polymerization. J. Biol. Chem. 258, 3207-3214 (1983).
26. Sobott, F., Hernandez, H., McCammon, M. G., Tito, M. A. & Robinson, C. V. A tandem mass spectrometer for improved transmission and analysis of large macromolecular assemblies. Anal. Chem. 74, 1402-1407 (2002).
27. Ruotolo, B. T. et al. Evidence for macromolecular protein rings in the absence of bulk water. Science 310, 1658-1661 (2005).
28. McCammon, M. G., Hernandez, H., Sobott, F. & Robinson, C. V. Tandem mass spectrometry defines the stoichiometry and quaternary structural arrangement of tryptophan molecules in the multiprotein complex TRAP. J. Am. Chem. Soc. 126, 5950-5951 (2004).
29. 1-42 oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J. Neurochem. 95, 834-847 (2005).
30. Lomakin, A., Chung, D. S., Benedek, G. B., Kirschner, D. A. & Teplow, D. B. On the nucleation and growth of amyloid β-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl Acad. Sci. USA 93, 1125-1129 (1996).
31. Wyttenbach, T., Kemper, P. R. & Bowers, M. T. Design of a new electrospray ion mobility mass spectrometer. Int. J. Mass Spectrom. 212, 13-23 (2001).
32. Mason, E. A. & McDaniel, E. W. Transport Properties of Ions in Gases (Wiley, 1988).